"Varian" linear accelerator
Taiwan·Risk Class 2·Varian Medical Systems China Co. Ltd.·Registered Feb 24, 2017 – Feb 24, 2022Cancelled- Analysis ID
- 903808cb8f3d28fb1a5686387678617f
- Customs Code
- DHAS9200081602
- Manufacturer
- Varian Medical Systems China Co. Ltd.
- Manufacturer Country
- China
- Authorized Representative
- Varian Medical Systems Taiwan Co., Ltd.
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- P Radiology Science
- Product Type (Level 2)
- P.5050 Medical Charged Particle Radiotherapy System
- Import Information
- Input;; Chinese goods;; The use of this device shall comply with the provisions of the "Administrative Measures for the Implementation or Use of Medical Devices for Specific Medical Technology Inspection and Testing". Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
- Registration Date
- Feb 24, 2017
- Expiry Date
- Feb 24, 2022
- Cancellation Date
- Apr 12, 2024
- Status
- Logged out
- Reason
- 許可證已逾有效期
Top companies providing products similar to ""Varian" linear accelerator"
Recently registered similar products
Access comprehensive regulatory information for "Varian" linear accelerator in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 903808cb8f3d28fb1a5686387678617f and manufactured by Varian Medical Systems China Co. Ltd.. The authorized representative in Taiwan is Varian Medical Systems Taiwan Co., Ltd..
This page provides complete technical specifications, regulatory compliance details, 4 companies making similar products including Varian Medical Systems Haan GmbH, Manufacturing Site Kemnath;; Varian Medical Systems, Inc, Varian Medical Systems UK Ltd., and 4 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.